NO943653D0 - Rekombinante, humane HIV-nöytraliserende monoklonale antistoffer for forebyggelse og behandling av HIV-infeksjon - Google Patents

Rekombinante, humane HIV-nöytraliserende monoklonale antistoffer for forebyggelse og behandling av HIV-infeksjon

Info

Publication number
NO943653D0
NO943653D0 NO943653A NO943653A NO943653D0 NO 943653 D0 NO943653 D0 NO 943653D0 NO 943653 A NO943653 A NO 943653A NO 943653 A NO943653 A NO 943653A NO 943653 D0 NO943653 D0 NO 943653D0
Authority
NO
Norway
Prior art keywords
prevention
treatment
hiv
monoclonal antibodies
recombinant human
Prior art date
Application number
NO943653A
Other languages
English (en)
Other versions
NO943653L (no
Inventor
Emilio A Emini
Anthony J Conley
George E Mark
L Syd Johnson
David S Pfarr
Original Assignee
Merck & Co Inc
Medimmune Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc, Medimmune Inc filed Critical Merck & Co Inc
Publication of NO943653D0 publication Critical patent/NO943653D0/no
Publication of NO943653L publication Critical patent/NO943653L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO943653A 1992-04-01 1994-09-30 Rekombinante, humane HIV-nöytraliserende monoklonale antistoffer for forebyggelse og behandling av HIV-infeksjon NO943653L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86170192A 1992-04-01 1992-04-01
PCT/US1993/002629 WO1993019785A1 (en) 1992-04-01 1993-03-23 Recombinant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infection

Publications (2)

Publication Number Publication Date
NO943653D0 true NO943653D0 (no) 1994-09-30
NO943653L NO943653L (no) 1994-11-30

Family

ID=25336532

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943653A NO943653L (no) 1992-04-01 1994-09-30 Rekombinante, humane HIV-nöytraliserende monoklonale antistoffer for forebyggelse og behandling av HIV-infeksjon

Country Status (19)

Country Link
EP (1) EP0577243A3 (no)
JP (1) JPH06217791A (no)
KR (1) KR950700761A (no)
CN (1) CN1081716A (no)
AU (2) AU3928593A (no)
BG (1) BG99074A (no)
CA (1) CA2093099A1 (no)
CZ (1) CZ239694A3 (no)
FI (1) FI944561A (no)
HU (1) HUT70461A (no)
IL (1) IL105145A0 (no)
MX (1) MX9301858A (no)
NO (1) NO943653L (no)
NZ (1) NZ251582A (no)
RU (1) RU94045907A (no)
SK (1) SK116294A3 (no)
WO (1) WO1993019785A1 (no)
YU (1) YU22693A (no)
ZA (1) ZA932308B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE390441T1 (de) * 1998-10-30 2008-04-15 Novozymes As Niedrigallergene proteinvarianten
RU2221873C2 (ru) * 2001-04-24 2004-01-20 Закрытое акционерное общество "АСГЛ-Фармацевтические Инновации" Способ получения каталитических антител (варианты), антигены для иммунизации и нуклеотидная последовательность
US7560529B2 (en) 2001-04-24 2009-07-14 FDS Pharma Method for producing catalytic antibodies (variants), antigens for immunization and nucleotide sequence
FR2844455B1 (fr) * 2002-09-13 2007-12-14 Lab Francais Du Fractionnement Traitement des pathologies echappant a la reponse immune par des anticorps optimises
ES2528738T3 (es) * 2003-02-20 2015-02-12 The Chemo-Sero-Therapeutic Research Institute Método para potenciar la eficacia de una preparación de un anticuerpo monoclonal
CA2697370A1 (en) * 2007-08-24 2009-03-05 Novartis Ag Hiv env proteins with modifications in the v3 loop
ES2623794T3 (es) 2008-12-09 2017-07-12 Gilead Sciences, Inc. Intermedios para la preparación de moduladores de receptores tipo toll
WO2015117008A2 (en) * 2014-01-31 2015-08-06 The Rockefeller University Broadly neutralizing anti-hiv antibodies and epitope therefor
CA2954056C (en) * 2014-07-11 2020-04-28 Gilead Sciences, Inc. Modulators of toll-like receptors for the treatment of hiv
JP2017526730A (ja) 2014-09-16 2017-09-14 ギリアード サイエンシーズ， インコーポレイテッド Ｔｏｌｌ様受容体モジュレーターの固体形態
WO2021227138A1 (zh) * 2020-05-09 2021-11-18 江苏省疾病预防控制中心(江苏省公共卫生研究院) 针对新型冠状病毒的单克隆抗体或其抗原结合部分

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2520464B2 (ja) * 1987-05-29 1996-07-31 タノツクス・バイオシステムズ・インコーポレーテツド Ｈｉｖ―１を中和するモノクロ―ナル抗体
EP0311228A3 (en) * 1987-10-09 1990-05-02 Repligen Corporation Recombinant polypeptides and their uses, including assay for aids virus
JPH05506561A (ja) * 1989-06-05 1993-09-30 レプリゲン・コーポレーション ＨＩＶ―１　ＭＮ　ｇｐ１２０のヒトモノクローナル抗体
EP0535154A4 (en) * 1990-06-15 1993-12-01 New York University Heterohybridomas producing human monoclonal antibodies to hiv-1
WO1993015202A1 (en) * 1992-01-29 1993-08-05 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Aamp-1, a protein with local homologies to hiv-1 env and nef proteins

Also Published As

Publication number Publication date
MX9301858A (es) 1994-03-31
WO1993019785A1 (en) 1993-10-14
NO943653L (no) 1994-11-30
HUT70461A (en) 1995-10-30
HU9402824D0 (en) 1994-11-28
FI944561A0 (fi) 1994-09-30
FI944561A (fi) 1994-09-30
CA2093099A1 (en) 1993-10-02
RU94045907A (ru) 1996-11-10
CZ239694A3 (en) 1995-07-12
CN1081716A (zh) 1994-02-09
BG99074A (en) 1995-11-30
EP0577243A3 (en) 1994-11-02
JPH06217791A (ja) 1994-08-09
YU22693A (sh) 1997-01-08
AU3928593A (en) 1993-11-08
NZ251582A (en) 1997-07-27
IL105145A0 (en) 1993-07-08
ZA932308B (en) 1994-09-30
KR950700761A (ko) 1995-02-20
EP0577243A2 (en) 1994-01-05
AU3563093A (en) 1993-10-07
SK116294A3 (en) 1996-11-06
AU658987B2 (en) 1995-05-04

Similar Documents

Publication Publication Date Title
NO994639D0 (no) Antimikrobiell forebyggelse og behandling av humant immunsviktvirus og andre infeksiöse sykdommer
MX9101046A (es) Anticuerpos novedosos para el tratamiento y prevencion de infeccion de animales y el hombre
DE69636760D1 (de) Rekombinanter anti-cd4 antikörper zur menschlichen behandlung
NO910340D0 (no) Topiske preparater for behandling av menneskenegler.
ZA932445B (en) Novel antibodies for treatment and prevention of respiratory syncytial virus infection in animals and man
CA2192512A1 (en) Nm03 antibody materials and methods
NO943653D0 (no) Rekombinante, humane HIV-nöytraliserende monoklonale antistoffer for forebyggelse og behandling av HIV-infeksjon
AU4028895A (en) Vaccine and treatment method of Human Immunodeficiency Virus
NO940810D0 (no) Behandling av virusinfeksjoner
EP0628056A4 (en) TARGETED HUMAN IMMUNGLOBULINE TO PREVENT AND TREAT STAPHYLOCOCCEN INFECTIONS.
NO931246D0 (no) Sammensetninger for behandling av infeksjon og sykdom foraarsaket av hepatites b virus (hbv)
NO912942D0 (no) Vaksine for preventiv behandling av infeksjon av leverikte hos droevtyggere.
ID16598A (id) Metode pencegahan dan pengobatan penyakit-penyakit infeksi virus
DE69004451D1 (de) Prophylaxe und Behandlung von Herpesvirus-Infektionen.
AU591017B2 (en) Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient
IL102815A0 (en) Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus
EP0655919A4 (en) TREATMENT OF VIRAL INFECTIONS IN MAN.
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
DK120892D0 (da) Treatment and prophylaxis of diseases caused by parasites, fungi or bacteria
NO960551D0 (no) Antistoff basert behandling av HIV infeksjon
BR9205290A (pt) Vacine e metodo de tratamento de infeccao do virus de imunodeficiencia humana
LTIP472A (en) Composition for the treatment of infection and disease caused by hepatit b virus
NO930550L (no) Metode og preparat for behandling av virale infeksjoner
EE9500019A (et) Farmatseutiline kompositsioon viirusliku infektsiooni ja neoplasma raviks
GB9521008D0 (en) Therapeutic treatment of viral infection in humans and animals

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application